Mount Sinai Creates Headache Registry to Study the Heterogeneity of Migraine and Develop Precision Medicine Treatment Approaches
Migraine headache treatment was revolutionized in recent years by new medicines and approaches, led by calcitonin gene-related peptide (CGRP) antagonists, oral preventive medications, and neuromodulation devices. However, migraine is a heterogeneous disorder with multiple etiologies and what works for one patient may not work for another.